I think if tga or FDA approval were received for recce 357 the jump would be multiples of SUD. The target market for the product is hard to quantify but an anti biotic which doesnt develop resistance after multiple uses. I just wish theyd get on and start the skin surface trial already? I dont know much but still that seems like lower hanging fruit.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
37.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $108.4M | |||
| Open | High | Low | Value | Volume |
| 38.0¢ | 39.0¢ | 36.5¢ | $39.00K | 102.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9999 | 37.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.0¢ | 2108 | 1 |
View Market Depth
| Last trade - 16.10pm 08/08/2025 (20 minute delay) ? |
| RCE (ASX) Chart |